Relay Therapeutics, Inc.

RLAYNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$15.4M

▲ 53.4% YoY

Net Income

-$276.5M

▲ 18.1% YoY

EPS

$-1.61

▲ 31.8% YoY

Cash

$84.0M

▼ 32.4% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.